alpha-aminopyridine has been researched along with Impotence in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, C; Li, Y; Wang, B; Wen, J; Xu, G; Zhang, N; Zhang, Z | 1 |
Attkins, N; Betts, A; Heatherington, AC; Hepworth, D | 1 |
1 trial(s) available for alpha-aminopyridine and Impotence
Article | Year |
---|---|
Pharmacokinetics and elucidation of the rates and routes of N-glucuronidation of PF-592379, an oral dopamine 3 agonist in rat, dog, and human.
Topics: Administration, Oral; Aminopyridines; Animals; Biometry; Blood Proteins; Caco-2 Cells; Dogs; Dopamine Agonists; Drug Evaluation, Preclinical; Erectile Dysfunction; Female; Glucuronosyltransferase; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microsomes, Liver; Morpholines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3 | 2010 |
1 other study(ies) available for alpha-aminopyridine and Impotence
Article | Year |
---|---|
A2B Adenosine Receptor Agonist Improves Erectile Function in Diabetic Rats.
Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Animals; Cyclic AMP; Diabetes Mellitus, Experimental; Electric Stimulation; Erectile Dysfunction; Male; Muscle, Smooth; Neurons; Penile Erection; Penis; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; RNA, Messenger | 2015 |